Parkinson's Disease Neuroprotection Clinical Trial

$5,508U10FY2014NSNIH

Rbhs-Robert Wood Johnson Medical School, Piscataway NJ

Investigators

Linked publications, trials & patents

Paper 31158942 Paper 29558420 Paper 27743701 Paper 26751506 Paper 23079770 Paper 22496398 Paper 20598621 Paper 20131372 Paper 19452561 Paper 19205066 Paper 18803996 Paper 18520981 Paper 17357141 Paper 17261742 Paper 17200487 Paper 16481597

Abstract

DESCRIPTION (provided by applicant): The Parkinson's disease neuroprotection clinical trial is currently trying to determine if creatine is neuroprotective in the treatment of Parkinson's disease. As part of this multicenter trial, we have enrolled 21 patients and are currently followin 20 of these patients. We plan to continue to retain and follow these patients in the trial for the next 3 years or to completion (see specific aims section).

View original record on NIH RePORTER →